Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Yearly performance comparison of index funds helps you rank funds by year, track changes, and refine your allocation strategy today.
19,372 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
In a market where dividends among healthcare firms can be elusive, two names stand out for investors seeking income n...
SoundHound AI stock has slipped in 2026, leaving investors to weigh risk against opportunity. This guide breaks down ...
A new Ethereum-based play-to-earn title, Meme Punch, launches its medieval arena with MEPU rewards. The game blends m...
FuelCell Energy leads a hydrogen stock rebound with a 15% jump as investors chase AI data center exposure. Bloom Ener...
The AI hype has captivated many investors, but the long game can be found in the industrial sector. This guide highli...
A clear look at Copart's 2026 earnings outlook, the drivers behind revenue, and what this could mean for investors. R...
A prominent investor reduced its position in a leading sports tech stock, triggering a market rally of questions. Thi...
The energy boom is reshaping long-term investing. This article dives into two stock picks that the smartest players a...
A steady stream of income can anchor a volatile market. Here are two dependable dividend stocks I’d double my positio...
Indianapolis offers affordable entry and steady rental demand for buyers, yet pockets of foreclosures add risk. This ...
Bitcoin moved back toward the $80,000 mark as global markets priced in a potential de-escalation in Middle East tensi...